Shi Jian, Wang Xinwen, Lyu Lingyun, Jiang Hui, Zhu Hao-Jie
Department of Clinical Pharmacy, University of Michigan, Ann Arbor, MI 48109, United States.
Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA 15213, United States.
Drug Metab Pharmacokinet. 2018 Apr;33(2):133-140. doi: 10.1016/j.dmpk.2018.03.003. Epub 2018 Mar 10.
Human hepatic cell lines are widely used as an in vitro model for the study of drug metabolism and liver toxicity. However, the validity of this model is still a subject of debate because the expressions of various proteins in the cell lines, including drug-metabolizing enzymes (DMEs), can differ significantly from those in human livers. In the present study, we first conducted an untargeted proteomics analysis of the microsomes of the cell lines HepG2, Hep3B, and Huh7, and compared them to human livers using a sequential window acquisition of all theoretical mass spectra (SWATH) method. Furthermore, high-resolution multiple reaction monitoring (MRM-HR), a targeted proteomic approach, was utilized to compare the expressions of pre-selected DMEs between human livers and the cell lines. In general, the SWATH quantifications were in good agreement with the MRM-HR analysis. Over 3000 protein groups were quantified in the cells and human livers, and the proteome profiles of human livers significantly differed from the cell lines. Among the 101 DMEs quantified with MRM-HR, most were expressed at substantially lower levels in the cell lines. Thus, appropriate caution must be exercised when using these cell lines for the study of hepatic drug metabolism and toxicity.
人肝细胞系被广泛用作药物代谢和肝毒性研究的体外模型。然而,由于细胞系中各种蛋白质的表达,包括药物代谢酶(DMEs),可能与人类肝脏中的表达有显著差异,因此该模型的有效性仍然是一个有争议的话题。在本研究中,我们首先对HepG2、Hep3B和Huh7细胞系的微粒体进行了非靶向蛋白质组学分析,并使用所有理论质谱的顺序窗口采集(SWATH)方法将它们与人类肝脏进行了比较。此外,还利用高分辨率多反应监测(MRM-HR)这一靶向蛋白质组学方法,比较人类肝脏和细胞系之间预先选择的DMEs的表达。总体而言,SWATH定量结果与MRM-HR分析结果高度一致。在细胞和人类肝脏中对3000多个蛋白质组进行了定量,人类肝脏的蛋白质组图谱与细胞系有显著差异。在用MRM-HR定量的101种DMEs中,大多数在细胞系中的表达水平显著较低。因此,在使用这些细胞系进行肝脏药物代谢和毒性研究时必须谨慎。